Remote functionalization of SCH 39166: Discovery of potent and selective benzazepine dopamine D1 receptor antagonists

被引：6
作者：
Sasikumar, T. K. [1 ]
Burnett, Duane A. [1 ]
Greenlee, William J. [1 ]
Smith, Michelle [1 ]
Fawzi, Ahmad [1 ]
Zhang, Hongtao [1 ]
Lachowicz, Jean E. [1 ]
机构：
[1] Merck Res Labs, Dept Med Chem & Metab Disorders, Kenilworth, NJ 07033 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 03期
关键词：
SCH; 39166; Ecopipam; Benzazepine; Dopamine antagonist; Obesity; D1; SCH-39166; ANALOGS; BINDING; INVIVO;
D O I：
10.1016/j.bmcl.2009.12.094
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of novel benzazepine derived dopamine D-1 antagonists have been discovered. These compounds are highly potent at D1 and showed excellent selectivity over D-2 and D-4 receptors. SAR studies revealed that a variety of functional groups are tolerated on the D-ring of known tetracyclic benzazepine analog 2, SCH 39166, leading to compounds with nanomolar potency at D-1 and good selectivity over D-2-like receptors. Published by Elsevier Ltd.
引用
收藏
页码：832 / 835
页数：4
相关论文
共 22 条
  • [1] Aebischer E, 1998, HETEROCYCLES, V48, P2225
  • [2] NNC-112, NNC-687 AND NNC-756, NEW SELECTIVE AND HIGHLY POTENT DOPAMINE D1 RECEPTOR ANTAGONISTS
    ANDERSEN, PH
    GRONVALD, FC
    HOHLWEG, R
    HANSEN, LB
    GUDDAL, E
    BRAESTRUP, C
    NIELSEN, EB
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 219 (01) : 45 - 52
  • [3] Randomized controlled trials of the D1/D5 antagonist ecopipam for weight loss in obese subjects
    Astrup, Arne
    Greenway, Frank L.
    Ling, Walter
    Pedicone, Lisa
    Lachowicz, Jean
    Strader, Catherine D.
    Kwan, Rudolf
    [J]. OBESITY, 2007, 15 (07) : 1717 - 1731
  • [4] STUDIES DIRECTED TOWARDS TOTAL SYNTHESES OF THE TROPOLOISOQUINOLINE ALKALOIDS GRANDIRUBRINE AND IMERUBRINE .1. PREPARATION OF 2 4,5,6-TRIMETHOXYCYCLOPENT[IJ]ISOQUINOLIN-7-ONES AND THEIR RESPONSE TO ROBINSON ANNULATION CONDITIONS
    BANWELL, MG
    BONADIO, A
    TURNER, KA
    IRELAND, NK
    MACKAY, MF
    [J]. AUSTRALIAN JOURNAL OF CHEMISTRY, 1993, 46 (03) : 325 - 351
  • [5] SYNTHESIS AND RECEPTOR AFFINITIES OF SOME CONFORMATIONALLY RESTRICTED ANALOGS OF THE DOPAMINE D1 SELECTIVE LIGAND (5R)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL
    BERGER, JG
    CHANG, WK
    CLADER, JW
    HOU, D
    CHIPKIN, RE
    MCPHAIL, AT
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (08) : 1913 - 1921
  • [6] COFFIN V, 1999, Patent No. 9921540
  • [7] COFFIN VL, 1999, Patent No. 19990301
  • [8] A convenient synthesis of 3,4-dimethoxy-5-hydroxybenzaldehyde
    Ellis, JE
    Lenger, SR
    [J]. SYNTHETIC COMMUNICATIONS, 1998, 28 (09) : 1517 - 1524
  • [9] Development of an efficient process for the preparation of Sch 39166: Aziridinium chemistry on scale
    Gala, D
    Dahanukar, VH
    Eckert, JM
    Lucas, BS
    Schumacher, DP
    Zavialov, IA
    Buholzer, P
    Kubisch, P
    Mergelsberg, I
    Scherer, DZ
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2004, 8 (05) : 754 - 768
  • [10] Gold E. H., 1981, U. S. Patent, Patent No. 4284555
123